Separation is our science, collaboration is our strategy

About Sepax Bioscience

For over two decades, Sepax has been at the forefront of chromatography innovation, providing high-performance resins that enable the purification of life-saving biotherapeutics.

Our Mission

To accelerate the development and manufacturing of biopharmaceuticals through innovative chromatography solutions that deliver superior performance, reliability, and value.

We believe that every patient deserves access to effective therapies. By continuously improving our purification technologies, we help our customers bring these therapies to market faster and more affordably.

20+
Years of Innovation
500+
Global Customers
60+
Countries Served
100+
Products

Our Values

The principles that guide everything we do.

Scientific Excellence

We are driven by rigorous science and continuous innovation in chromatography technology.

Customer Partnership

We work closely with our customers to understand their unique challenges and deliver tailored solutions.

Quality First

Every product meets the highest standards of quality, consistency, and regulatory compliance.

Global Impact

Our resins enable life-saving therapeutics that improve health outcomes worldwide.

Our Journey

Key milestones in our history of innovation.

1
2002
Sepax Technologies founded in Delaware, USA
2
2005
Launch of first Protein A affinity resin
3
2010
Expansion into Asian markets
4
2015
GMP manufacturing facility certification
5
2018
Introduction of mRNA purification solutions
6
2020
COVID-19 vaccine production support
7
2023
Next-gen multimodal resins launch
8
2025
Global distribution network expansion

Join Our Team

We are always looking for talented individuals who share our passion for science and innovation.